Resistance Patterns ofHaemophilus influenzae
- 1 January 1999
- journal article
- Published by Taylor & Francis in Journal of Chemotherapy
- Vol. 11 (sup1) , 44-50
- https://doi.org/10.1179/joc.1999.11.supplement-2.44
Abstract
Haemophilus influenzae is an important respiratory tract pathogen, and the prevalence of strains resistant to the antibiotics used to treat it has increased since the 1970s. Data on H. influenzae have been gathered in the Alexander Project, an ongoing, international surveillance study. They reveal that beta-lactamase production is the primary mechanism for H. influenzae resistance and that the resistance has a wide geographical variation, reaching critical levels in some countries. Unlike many techniques used in the past, Alexander Project methods provide accurate, reproducible susceptibility data, allowing the comparison of resistance prevalence over time and between areas. Traditional antimicrobial breakpoints are being superseded by more accurate and clinically relevant methods of predicting drug efficacy, such as time above the MIC, AUC:MIC ratios and pharmacodynamic breakpoints. Continued surveillance for resistance and susceptibility testing of H. influenzae is vital to maximize the benefits of antimicrobial therapy and to contain the spread of infection.Keywords
This publication has 15 references indexed in Scilit:
- State‐of‐the‐Art Clinical Article: Pharmacokinetic/Pharmacodynamic Parameters: Rationale for Antibacterial Dosing of Mice and MenClinical Infectious Diseases, 1998
- Epidémiologie bactérienne régionale des surinfections bronchiquesMedecine Et Maladies Infectieuses, 1994
- Determination of antimicrobial susceptibilities of Canadian isolates of Haemophilus influenzae and characterization of their beta-lactamases. Canadian Haemophilus Study GroupAntimicrobial Agents and Chemotherapy, 1994
- Susceptibility of bacterial respiratory pathogens to amoxicillin and amoxicillin-clavulanic acidEuropean Journal of Clinical Microbiology & Infectious Diseases, 1994
- Evaluating clinical outcomes of respiratory infectionInternational Journal of Antimicrobial Agents, 1993
- The New Macrolide Antibiotics: Azithromycin, Clarithromycin, Dirithromycin, and RoxithromycinAnnals of Pharmacotherapy, 1992
- The second European collaborative study on the frequency of antimicrobial resistance inHaemophilus influenzaeEuropean Journal of Clinical Microbiology & Infectious Diseases, 1990
- Acute and chronic bronchitisPostgraduate Medicine, 1989
- AMPICILLIN-RESISTANT HÆMOPHILUS INFLUENZÆ TYPE B POSSESSING A TEM-TYPE β-LACTAMASE BUT LITTLE PERMEABILITY BARRIER TO AMPICILLINThe Lancet, 1975
- Haemophilus influenzae Type B Resistant to AmpicillinJAMA, 1974